Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy

Journal of the American Society of Nephrology

Volumn 7, Issue 10, 1996, Pages 2202-2212

  Morrissey, Jeremiah J ^a   Ishidoya, Shigeto ^a   McCracken, Ruth ^a   Klahr, Saulo ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Collagen IV; Macrophages; TGF 1; TIMP 1

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FIBROSIS; MACROPHAGE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; URETER OBSTRUCTION;

EID: 0030404820     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Klahr S, Harris K, Purkerson ML: Effects of obstruction on renal function. Pediatr Nephrol 1988;2:34-42.
2. Klahr S: New insights into the consequences and the mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis 1991;18:689-699.
3. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 1995;47:1285-1294.
4. Kuncio GS, Neilson EG, Haverty T: Mechanisms of tubulointerstitial fibrosis. Kidney Int 1991;39:550-556.
5. Lafayette R, Mayer G, Meyer T: The effects of blood pressure reduction on cyclosporine nephrotoxicity in the rat. J Am Soc Nephrol 1993;3:1892-1899.
6. Diamond JR, Anderson S: Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis: Amelioration by angiotensin I converting enzyme inhibition. Am J Pathol 1990;137:1323-1332.
7. Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S: Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed kidney of the rat. Kidney Int 1994;45:1637-1647.
8. Burdmann EA, Andoh TF, Nast CC, et al: Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. Am J Physiol 1995;269:F491-F499.
9. El-Dahr SS, Gee J, Dipp S, Hanss BG, Van RC, Chao J: Upregulation of renin-angiotensin system and down-regulation of kallikrein in obstructive nephropathy. Am J Physiol 1993;264:F874-F881.
10. Kaneto H, Morrissey J, Klahr S: Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 1993;44:313-321.
11. Pimentel JL Jr, Sundell CL, Wang S, Kopp JB, Montero A, Martinez-Maldonado M: Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int 1995;48: 1233-1246.
12. 1 receptors during neonatal ureteral obstruction. Am J Physiol 1995;268: F1117-F1123.
13. Sawczuk IS, Hoke G, Olsson CA, Connor J, Buttyan R: Gene expression in response to acute unilateral ureteral obstruction. Kidney Int 1989;35:1315-1319.
14. Gobé GC, Buttyan R, Wyburn KRL, Etheridge MR, Smith PJ: Clusterin expression and apoptosis in tissue remodeling associated with renal regeneration. Kidney Int 1995;47:411-420.
15. Dvergsten J, Manivel JC, Correa-Rotter R, Rosenberg ME: Expression of clusterin in human renal diseases. Kidney Int 1994;45:828-835.
16. Liao J, Homey C: Specific receptor-guanine nucleotide binding protein interaction mediates the release of endothelium-derived relaxing factor. Circ Res 1992;70: 1018-1026.
17. Warren JB, Loi RK: Captopril increases skin microvascular blood flow secondary to bradykinin, nitric oxide, and prostaglandins. FASEB J 1995;9:411-418.
18. Mombouli J-V, Illiano S, Nagao T, Scott-Burden T, Vanhoutte PM: Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res 1992;71:137-144.
19. Reyes AA, Purkerson ML, Karl I, Klahr S: Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 1992;20:168-176.
20. Reyes AA, Karl I, Kissane J, Klahr S: L-arginine administration prevents glomerular hyperfiltration, and decreases proteinuria in diabetic rats. J Am Soc Nephrol 1993;4:1039-1045.
21. De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB: Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 1993;92:1859-1865.
22. Reyes AA, Porras BH, Chasalow FI, Klahr S: L-arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis. Kidney Int 1994;45:1346-1354.
23. Ashab I, Peer G, Blum M, et al.: Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 1995;47: 1515-1521.
24. Ingrain A, Parbtani A, Thai K, et al.: Dietary supplementation with L-arginine limits cell proliferation in the remnant glomerulus. Kidney Int 1995;48:1857-1865.
25. Ishidoya S, Morrissey J, McCracken R, Klahr S: Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats. Kidney Int, 1996;49:1110-1119.
26. Welsh N, Eizirik DL, Bendtzen K, Sandler S: Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 1991;129:3167-3173.
27. Schreiner GF, Harris KPG, Purkerson ML, Klahr S: The immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney. Kidney Int 1988;34: 487-493.
28. Sharma AK, Mauer SM, Kim Y, Michael AF: Altered expression of matrix metalloproteinase-2, TIMP, and TIMP-1 in obstructive nephropathy. J Lab Clin Med 1995;125:754-761.
29. Bouriquet N, Casellas D: Chronic L-NAME hypertension in rats and autoregulation of juxtamedullary preglomerular vessels. Am J Physiol 1995;269:F190-F197.
30. 1 in experimental hydronephrosis. Am J Physiol 1994;266:F926-F933.
31. Eddy AA, Giachelli CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 1995;47: 1546-1557.
32. Pichler RH, Franceschini N, Young BA, et al.: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 1995;6:1186-1196.
33. Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke JP: Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994;89: 2176-2182.
34. Suto T, Losonczy G, Qiu C, et al.: Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production. Kidney Int 1995; 48:1272-1277.
35. Chevalier RL, Thornhill BA, Gomez RA: EDRF modulates renal hemodynamics during unilateral ureteral obstruction in the rat. Kidney Int 1992;42:400-406.
36. Arnal J-F, Münzel T, Venema RC, et al.: Interactions between L-Arginine and L-glutamine change endothelial NO production; an effect independent of NO synthase substrate availability. J Clin Invest 1995;95:2565-2572.
37. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-4655.
38. Gauthier TW, Davenpeck KL, Lefer AM: Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol 1994;267:G562-G568.
39. Davenpeck KL, Gauthier TW, Lefer AM: Inhibition of endothelial-derived nitric oxide promotes p-selectin expression and actions in the rat microcirculation. Gastroenterology 1994;107:1050-1058.
40. Kolpakov V, Gordon D, Kulik TJ: Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res 1995; 76:305-309.
41. Tracntman H, Futterweit S, Singhal P: Nitric oxide modulates the synthesis of extracellular matrix proteins m cultured rat mesangial cells. Biochem Biophys Res Commun 1995;207:120-125.
42. Narita I, Border WA, Ketteler M, Noble NA: Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest 1995;72: 17-24.
43. Klahr S, Morrissey J: Renal disease: The two faces of nitric oxide. Lab Invest 1995;72:1-3.
44. Oliver J, MacDowell M, Tracy A: The pathogenesis of acute renal failure associated with traumatic and toxic injury Renal ischemia, nephrotoxic damage, and the ischemic episode. J Clin Invest 1951;30:1307-1351.
45. Flamenbaum W, McDonald FD, Dibona GF, Olsen DE: Micropuncture study of renal tubular factors in low-dose mercury poisoning. Nephron 1971;8:221-234.
46. Tanner GA, Steinhausen M: Kidney pressure after temporary artery occlusion in the rat. Am J Physiol 1976; 230:1173-1181.
47. Arendshorst WJ, Finn WF, Gottschalk CW, Lucas HK: Micropuncture study of acute renal failure following temporary renal ischemia in the rat. Kidney Int 1976; 10[Suppl 6]:S100-S105.